| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization.
|
Int Arch Allergy Immunol
|
2002
|
1.15
|
|
2
|
A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1.
|
J Immunol
|
2009
|
0.98
|
|
3
|
Mast cell-derived proteases control allergic inflammation through cleavage of IgE.
|
J Allergy Clin Immunol
|
2007
|
0.97
|
|
4
|
Molecular, structural, and immunologic relationships between different families of recombinant calcium-binding pollen allergens.
|
J Allergy Clin Immunol
|
2002
|
0.89
|
|
5
|
The cross-reactive calcium-binding pollen allergen, Phl p 7, reveals a novel dimer assembly.
|
EMBO J
|
2002
|
0.87
|
|
6
|
Identification of cross-reactive and genuine Parietaria judaica pollen allergens.
|
J Allergy Clin Immunol
|
2003
|
0.85
|
|
7
|
Three-dimensional structure of the cross-reactive pollen allergen Che a 3: visualizing cross-reactivity on the molecular surfaces of weed, grass, and tree pollen allergens.
|
J Immunol
|
2008
|
0.84
|
|
8
|
Staphylococcus aureus fibronectin-binding protein specifically binds IgE from patients with atopic dermatitis and requires antigen presentation for cellular immune responses.
|
J Allergy Clin Immunol
|
2011
|
0.81
|
|
9
|
Allergen cleavage by effector cell-derived proteases regulates allergic inflammation.
|
FASEB J
|
2006
|
0.79
|
|
10
|
Efficacy of a travelers' diarrhea vaccine system in travelers to India.
|
J Travel Med
|
2013
|
0.79
|
|
11
|
Immunogold electron microscopic localization of the 2 EF-hand calcium-binding pollen allergen Phl p 7 and its homologues in pollens of grasses, weeds and trees.
|
Int Arch Allergy Immunol
|
2008
|
0.77
|
|
12
|
Tree pollen allergens.
|
Clin Allergy Immunol
|
2004
|
0.76
|
|
13
|
Three-dimensional structure of the panallergen Phl p 7.
|
Int Arch Allergy Immunol
|
2003
|
0.75
|
|
14
|
Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO® n Children from a Japanese Encephalitis Virus -Endemic Region.
|
Pediatr Infect Dis J
|
2017
|
0.75
|
|
15
|
Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO® in Children - an Open-Label, Randomized, Active-Controlled, Phase 3 Study.
|
Pediatr Infect Dis J
|
2017
|
0.75
|